ClassID:

21647

A61K2300/00 - page 16 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#4501
20120308519
2012-12-06

Anti-arenaviral compounds

#4502
20120308518
2012-12-06

Methods of using regenerative cells in the treatment of stroke and related diseases and disorders

#4503
20120308517
2012-12-06

COMPOSITIONS FOR THE TREATMENT OF INFECTIOUS AND TUMOURAL DISEASES

#4504
20120308516
2012-12-06

Use of metallocene compounds for cancer treatment

#4505
20120308511
2012-12-06

Co-Therapy for Diabetic Conditions

#4506
20120308492
2012-12-06

Foamable oil-water emulsion

#4507
20120308483
2012-12-06

Treatment of sleep disturbances

#4508
20120302640
2012-11-29

ORAL FORMULATIONS

#4509
20120302639
2012-11-29

OMEGA 3 FORMULATIONS FOR TREATMENT OF RISK FACTORS FOR CARDIOVASCULAR DISEASE AND PROTECTION AGAINST SUDDEN DEATH

#4510
20120302621
2012-11-29

D-serine transporter inhibitors as pharmaceutical compositions for the treatment of visual system disorders

#4511
20120302616
2012-11-29

METHOD OF TREATMENT OF OBSESSIVE COMPULSIVE DISORDER WITH ONDANSETRON

#4512
20120302600
2012-11-29

Stable laquinimod preparations

#4513
20120302590
2012-11-29

METHODS AND COMPOSITIONS TO PREVENT ADDICTION

#4514
20120302589
2012-11-29

Methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy

#4515
20120302582
2012-11-29

Bifunctional metnase/intnase inhibitors and related compositions and methods of treatment of cancer

#4516
20120302579
2012-11-29

CANCER TREATMENT METHOD

#4517
20120302577
2012-11-29

TREATMENT OF GIST WITH MASITINIB

#4518
20120302564
2012-11-29

(1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases

#4519
20120302555
2012-11-29

METHOD OF TREATMENT USING EPROSARTAN

#4520
20120302538
2012-11-29

Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections

#4521
20120302532
2012-11-29

COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND CORTICOSTEROIDS

#4522
20120302529
2012-11-29

Method of treating actinic keratosis and basal cell carcinoma

#4523
20120302526
2012-11-29

METHODS FOR TREATING POST-TRAUMATIC STRESS DISORDER

#4524
20120302522
2012-11-29

Synergistic antiviral composition and use thereof

#4525
20120302520
2012-11-29

GEMCITABINE COMBINATION THERAPY

#4526
20120302507
2012-11-29

Liquid Product of Botulinum Toxin Type A

#4527
20120301600
2012-11-29

Edible mix and method of making the same

#4528
20120301560
2012-11-29

Compositions comprising extracts combined with extracts complexed with phospholipids, and their use

#4529
20120301559
2012-11-29

DIETARY REGIMENS USEFUL FOR MIMICKING CALORIC RESTRICTIONS

#4530
20120301558
2012-11-29

Herbal tea without excipient used as milk supplement and method of preparing the same

#4531
20120301557
2012-11-29

METHOD OF ASSISTING WITH DIGESTIVE UPSETS USING A CONFECTION-BASED DELIVERY OF PEPPERMINT OIL AND GINGER

#4532
20120301551
2012-11-29

COMPOUNDS AND COMPOSITIONS FOR TREATING NEURONAL DEATH OR NEUROLOGICAL DYSFUNCTION

#4533
20120301549
2012-11-29

COMPLEX FORMULATION COMPRISING ASPIRIN COATED WITH BARRIER CONTAINING HYDROPHOBIC ADDITIVE, AND HMG-COA REDUCTASE INHIBITOR

#4534
20120301548
2012-11-29

Oral complex composition comprising pseudoephedrine and levocetirizine

#4535
20120301538
2012-11-29

PHARMACEUTICAL COMPOSITIONS FOR THE STIMULATION OF STEM CELLS

#4536
20120301537
2012-11-29

LIPOSOME CONTAINING shRNA MOLECULE TARGETING A THYMIDYLATE SYNTHASE AND USE THEREOF

#4537
20120301535
2012-11-29

Combination peptide-nanoparticles and delivery systems incorporating same

#4538
20120301510
2012-11-29

TOLEROGENIC SYNTHETIC NANOCARRIERS COUPLED TO CD1D-RESTRICTED ANTIGENS AND METHODS OF USE

#4539
20120301498
2012-11-29

CONTROLLED RELEASE OF IMMUNOSUPPRESSANTS FROM SYNTHETIC NANOCARRIERS

#4540
20120301495
2012-11-29

Antigen peptide and use thereof

#4541
20120301489
2012-11-29

Jagged-binding agents and uses thereof

#4542
20120301478
2012-11-29

Pharmaceutical for Preventing or Treating Disorders Accompanied by Ocular Angiogenesis and/or Elevated Ocular Vascular Permeability

#4543
20120301472
2012-11-29

Reagents and treatment methods for autoimmune diseases

#4544
20120301468
2012-11-29

ANTI-MN ANTIBODIES AND METHODS OF USING SAME

#4545
20120301460
2012-11-29

Subcutaneously administered anti-IL-6 receptor antibody

#4546
20120301459
2012-11-29

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC)

#4547
20120301444
2012-11-29

Amnion-derived cell compositions, methods of making and uses thereof

#4548
20120301433
2012-11-29

BACTERIOPHAGES EXPRESSING AMYLOID PEPTIDES AND USES THEREOF

#4549
20120301432
2012-11-29

Boswellia low polar gum resin extract and its synergistic compositions

#4550
20120301430
2012-11-29

Thiophene analogues for the treatment or prevention of flavivirus infections

#4551
20120301425
2012-11-29

Antitumoral use of cabazitaxel

#4552
20120301409
2012-11-29

HOMEOPATHIC COMPOSITION AND METHOD FOR THE TREATMENT OF SKIN IRRITATIONS AND OTHER SKIN DISEASES

#4553
20120301407
2012-11-29

Method of treating a mammalian teat and related compositions

#4554
20120296084
2012-11-22

Carbapenem antibacterials with gram-negative activity and processes for their preparation

#4555
20120296081
2012-11-22

Carrageenan Based Antimicrobial Compositions

#4556
20120295982
2012-11-22

TREATING HUMAN MALE COPD PATIENTS WITH ORAL BEDORADRINE

#4557
20120295974
2012-11-22

-conjugated linoleic acid compositions and use thereof

#4558
20120295968
2012-11-22

Pharmaceutical composition comprising Cannabinoids

#4559
20120295965
2012-11-22

FUSED THIOPHENES AS DUAL INHIBITORS OF EGFR/VEGFR AND THEIR USE IN THE TREATMENT OF CANCER

#4560
20120295952
2012-11-22

TREATMENT OF FILAGGRIN (FLG) RELATED DISEASES BY MODULATION OF FLG EXPRESSION AND ACTIVITY

#4561
20120295945
2012-11-22

Buccal, polar and non-polar spray containing ondansetron

#4562
20120295933
2012-11-22

TREATMENT OF COPD, GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD), FOOD ALLERGIES AND OTHER GASTROINTESTINAL CONDITIONS AND DISORDERS AMELIORATED BY PROPER HISTAMINE MANAGEMENT USING A COMBINATION OF HISTIDINE DECARBOXYLASE INHIBATORS, LRA DRUGS, ANTI-H1 AND/OR ANTI-H2 DRUGS

#4563
20120295932
2012-11-22

METHOD FOR THE TREATMENT OF CANCER

#4564
20120295929
2012-11-22

Compositions and methods for treating and preventing dermatoses

#4565
20120295918
2012-11-22

Non-peptide thrombopoietin receptor agonist in the treatment of cancer and pre-cancerous syndromes

#4566
20120295914
2012-11-22

COMBINATION OF ADRENERGIC RECEPTOR AGONIST ALPHA-1 OR ALPHA-2, PREFERABLY BRIMONIDINE WITH FILLERS, PREFERABLY HYALURONIC ACID

#4567
20120295912
2012-11-22

Piperazinylpiperidine derivatives as chemokine receptor antagonists

#4568
20120295911
2012-11-22

Novel Compounds and Compositions for Treatment of Breathing Control Disorders or Diseases

#4569
20120295908
2012-11-22

Pyrimidinyl pyridazinone derivatives

#4570
20120295898
2012-11-22

Antiviral Therapy

#4571
20120295893
2012-11-22

COMPOSITIONS AND METHODS OF COUNTERACTING RESIDUAL SEDATIVE EFFECTS OF SLEEP/ HYPNOTIC DRUGS

#4572
20120295878
2012-11-22

METHOD FOR THE TREATMENT OF CANCER

#4573
20120295873
2012-11-22

Branched soluble glucose polymers for peritoneal dialysis

#4574
20120295871
2012-11-22

Heparin-based compositions and methods for the inhibition of metastasis

#4575
20120295867
2012-11-22

METHOD AND PHARMACEUTICAL TO TREAT SPINAL DISCS

#4576
20120295864
2012-11-22

Method for treating acute myeloid leukemia

#4577
20120295861
2012-11-22

Combination Therapy With Organic Arsenicals

#4578
20120295858
2012-11-22

Use of Danshensu, Notoginsenoside R1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder

#4579
20120295846
2012-11-22

Pharmaceutical composition comprising a GLP-1 agonist, an insulin and methionine

#4580
20120295843
2012-11-22

COMBINATION THERAPY FOR THE TREATMENT OF HCV INFECTION

#4581
20120295840
2012-11-22

Treatment of infections with alpha thymosin peptides

#4582
20120295327
2012-11-22

Targeted therapeutic proteins

#4583
20120294960
2012-11-22

Orally administrable compositions comprising avocado/soybean unsaponifiables and lipoic acid and methods of administration

#4584
20120294957
2012-11-22

TREATMENT OF LUNG CANCER

#4585
20120294956
2012-11-22

Inhibition of dynamin related protein 1 to promote cell death

#4586
20120294955
2012-11-22

Use of arsenic for cancer therapy protection

#4587
20120294952
2012-11-22

ANTITUSSIVE COMPOSITIONS AND METHODS

#4588
20120294943
2012-11-22

Extended-release formulation for reducing the frequency of urination and method of use thereof

#4589
20120294936
2012-11-22

REDUCED MASS METFORMIN FORMULATIONS

#4590
20120294933
2012-11-22

Use of PVP-Iodine Liposomes for Treatment of Acne

#4591
20120294930
2012-11-22

Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof

#4592
20120294928
2012-11-22

Method of treating scars and β-catenin-mediated disorders using Nefopam compounds

#4593
20120294897
2012-11-22

Bioactive fraction of , pharmaceutical composition containing same, and combination with immunostimulants for treating cancer

#4594
20120294888
2012-11-22

Tolerogenic synthetic nanocarriers for allergy therapy

#4595
20120294867
2012-11-22

Method for EGFR directed combination treatment of non-small cell lung cancer

#4596
20120294860
2012-11-22

Medicament for treating and/or preventing cancer

#4597
20120294851
2012-11-22

Cancer therapies and pharmaceutical compositions used therein

#4598
20120294849
2012-11-22

Use of WF10 for treating allergic asthma, allergic rhinitis and atopic dermatitis

#4599
20120294831
2012-11-22

USE OF THIAZOLIDE COMPOUNDS FOR THE PREVENTION AND TREATMENT OF VIRAL DISEASES, CANCER AND DISEASES CAUSED BY INTRACELLULAR INFECTIONS

#4600
20120294830
2012-11-22

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

#4601
20120294812
2012-11-22

Oral care compositions

#4602
20120294796
2012-11-22

Antibodies reactive with B7-H3 and uses thereof

#4603
20120291875
2012-11-22

Citrate-based dialysate chemical formulations

#4604
20120289603
2012-11-15

Enhanced bimatoprost ophthalmic solution

#4605
20120289597
2012-11-15

NITRIC OXIDE AMINO ACID ESTERS FOR THE TREATMENT OF CHRONIC PAIN

#4606
20120289596
2012-11-15

Dermatological compositions comprising a fat or oil of an essential fatty acid triglyceride for treating of skin, mucosa, hair, nails, or scalp

#4607
20120289594
2012-11-15

ORAL DOSAGE FORM

#4608
20120289591
2012-11-15

Antimicrobial Compositions Containing Free Fatty Acids

#4609
20120289568
2012-11-15

COMBINATIONS OF OXYBUTYNIN AND SALIVARY STIMULANTS FOR THE TREATMENT OF OVERACTIVE BLADDER

#4610
20120289567
2012-11-15

COMBINATIONS OF DARIFENACIN AND SALIVARY STIMULANTS FOR THE TREATMENT OF OVERACTIVE BLADDER

#4611
20120289566
2012-11-15

COMBINATIONS OF FESOTERODINE AND SALIVARY STIMULANTS FOR THE TREATMENT OF OVERACTIVE BLADDER

#4612
20120289565
2012-11-15

COMBINATIONS OF TOLTERODINE AND SALIVARY STIMULANTS FOR THE TREATMENT OF OVERACTIVE BLADDER

#4613
20120289564
2012-11-15

COMBINATIONS OF OXYBUTYNIN AND SALIVARY STIMULANTS FOR THE TREATMENT OF OVERACTIVE BLADDER

#4614
20120289563
2012-11-15

COMBINATIONS OF IMIDAFENACIN AND SALIVARY STIMULANTS FOR THE TREATMENT OF OVERACTIVE BLADDER

#4615
20120289562
2012-11-15

COMBINATIONS OF DARIFENACIN AND SALIVARY STIMULANTS FOR THE TREATMENT OF OVERACTIVE BLADDER

#4616
20120289561
2012-11-15

COMBINATIONS OF FESOTERODINE AND SALIVARY STIMULANTS FOR THE TREATMENT OF OVERACTIVE BLADDER

#4617
20120289560
2012-11-15

COMBINATIONS OF TOLTERODINE AND SALIVARY STIMULANTS FOR THE TREATMENT OF OVERACTIVE BLADDER

#4618
20120289550
2012-11-15

COMPOSITION COMPRISING A COMBINATION OF OMEPRAZOLE AND LANSOPRAZOLE, AND A BUFFERING AGENT, AND METHODS OF USING SAME

#4619
20120289547
2012-11-15

COMBINATIONS OF PROPIVERINE AND SALIVARY STIMULANTS FOR THE TREATMENT OF OVERACTIVE BLADDER

#4620
20120289544
2012-11-15

Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder

#4621
20120289543
2012-11-15

Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder

#4622
20120289542
2012-11-15

CICLETANINE IN COMBINATION WITH ORAL ANTIDIABETIC AND/OR BLOOD LIPID-LOWERING AGENTS AS A COMBINATION THERAPY FOR DIABETES AND METABOLIC SYNDROME

#4623
20120289539
2012-11-15

COMBINATIONS OF TROSPIUM AND SALIVARY STIMULANTS FOR THE TREATMENT OF OVERACTIVE BLADDER

#4624
20120289534
2012-11-15

PACKAGE FOR IMPROVED TREATMENT OF CONDITIONS

#4625
20120289533
2012-11-15

Use of manzamine compounds in anti-cancer therapeutic regimens

#4626
20120289531
2012-11-15

COMBINATIONS OF TROSPIUM AND SALIVARY STIMULANTS FOR THE TREATMENT OF OVERACTIVE BLADDER

#4627
20120289530
2012-11-15

COMBINATIONS OF TROSPIUM AND SALIVARY STIMULANTS FOR THE TREATMENT OF OVERACTIVE BLADDER

#4628
20120289529
2012-11-15

COMBINATIONS OF TROSPIUM AND SALIVARY STIMULANTS FOR THE TREATMENT OF OVERACTIVE BLADDER

#4629
20120289517
2012-11-15

SOLID PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION

#4630
20120289514
2012-11-15

Pharmaceutical composition for treating alcohol dependency

#4631
20120289508
2012-11-15

Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof

#4632
20120289506
2012-11-15

5-membered nitrogen containing heterocyclic derivatives and pharmaceutical compositions comprising the same

#4633
20120289503
2012-11-15

Aqueous solution comprising 3-quinuclidinones for the treatment hyperproliferative, autoimmune and heart disease

#4634
20120289490
2012-11-15

COMPOSITIONS AND METHODS FOR ENHANCING CORTICOSTEROID DELIVERY

#4635
20120289489
2012-11-15

Non-sedating antihistamine injection formulations and methods of use thereof

#4636
20120289488
2012-11-15

Steroid-sparing effects of beta-adrenergic inverse agonists and uses thereof

#4637
20120289487
2012-11-15

Pharmaceutical Use of Multicyclic Compounds as Anti-Aids Agents

#4638
20120289486
2012-11-15

Treatment of eyelid dermatitis

#4639
20120289481
2012-11-15

COMPOSITIONS AND METHODS FOR TREATING CANCER

#4640
20120289476
2012-11-15

METHODS FOR TREATING METHYLMALONIC ACIDEMIA

#4641
20120289473
2012-11-15

Treatment and/or prevention of inflammation and cutaneous photodamage and photoprotection of the skin with a water-soluble extract from plant of genus

#4642
20120289464
2012-11-15

Method of treating coronary artery disease FGF-2

#4643
20120289452
2012-11-15

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING NECROSIS

#4644
20120288896
2012-11-15

NUCLEIC ACID MOLECULES ENCODING ANTI-AMYLOID-BETA ANTIBODIES

#4645
20120288571
2012-11-15

Antimicrobial agents and methods of use

#4646
20120288568
2012-11-15

METHODS AND COMPOSITIONS FOR TREATING OPHTHALMIC CONDITIONS VIA SERUM RETINOL, SERUM RETINOL BINDING PROTEIN (RBP), AND/OR SERUM RETINOL-RBP MODULATION

#4647
20120288567
2012-11-15

Opioid agonist formulations with releasable and sequestered antagonist

#4648
20120288561
2012-11-15

Delayed-release formulation for reducing the frequency of urination and method of use thereof

#4649
20120288560
2012-11-15

Methods for the Treatment of CNS-Related Conditions

#4650
20120288555
2012-11-15

Antiproliferative compositions comprising curcumin analogs and methods of producing and using same

#4651
20120288554
2012-11-15

CANFOSFAMIDE MONOTHERAPY FOR TREATING MULTIPLE MYELOMA

#4652
20120288553
2012-11-15

METHOD FOR CONTROLLING TOXICITY OF METALLIC PARTICLE AND LOW-TOXICITY COMPOSITE OF METALLIC NANOPARTICLE AND INORGANIC CLAY

#4653
20120288508
2012-11-15

Antibodies against clostridium difficile toxins and uses thereof

#4654
20120288506
2012-11-15

c-Kit antibodies and uses thereof

#4655
20120288497
2012-11-15

COMBINATION OF ANGIOPOIETIN-2 ANTAGONIST AND OF VEGF-A, KDR AND/OR FLT1 ANTAGONIST FOR TREATING CANCER

#4656
20120288495
2012-11-15

THERAPEUTIC COMPOSITIONS AND METHODS

#4657
20120288485
2012-11-15

USE OF JASMONE FOR MODULATING MELATONIN PRODUCTION AND CALCIFICATION OF THE PINEAL GLAND

#4658
20120288472
2012-11-15

REGULATION OF T CELL-MEDIATED IMMUNITY BY TRYPTOPHAN

#4659
20120288446
2012-11-15

Organophosphorous and multivalent metal compound compositions and methods

#4660
20120283671
2012-11-08

Anti-inflammatory analgesic adhesive patch for external use

#4661
20120283333
2012-11-08

Ophthalmic Compositions with an Amphoteric Surfactant, Hyaluronic Acid and Polyquaternium-1

#4662
20120283328
2012-11-08

Photosensitizer composition for treating skin disorders

#4663
20120283321
2012-11-08

USE OF GAMBIEROL FOR TREATING AND/OR PREVENTING NEURODEGENERATIVE DISEASES RELATED TO TAU AND BETA-AMYLOID

#4664
20120283285
2012-11-08

Treatment of solid tumors with rapamycin derivatives

#4665
20120283283
2012-11-08

METHODS FOR DETECTING ENHANCED RISK OF OPIOID-INDUCED HYPOXIA IN A PATIENT

#4666
20120283279
2012-11-08

COMBINATION

#4667
20120283278
2012-11-08

COMBINATION

#4668
20120283277
2012-11-08

Inhibitors of Bruton'S tyrosine kinase

#4669
20120283276
2012-11-08

Inhibitors of Bruton's tyrosine kinase

#4670
20120283266
2012-11-08

Lysine Specific Demethylase-1 inhibitors and their use

#4671
20120283244
2012-11-08

Association between 4-{3-[-hexahydrocyclopenta[]pyrrol-2(1)-yl]propoxy}benzamide and an acetylcholinesterase inhibitor, and pharmaceutical compositions containing it

#4672
20120283235
2012-11-08

Dermatologic and Cosmetic Compositions

#4673
20120283225
2012-11-08

Combination therapy for skin disorders

#4674
20120283215
2012-11-08

Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same

#4675
20120283212
2012-11-08

Use of polysaccharides for treating stress and anxiety

#4676
20120283205
2012-11-08

COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS

#4677
20120283187
2012-11-08

Controlled release composition and method of producing the same

#4678
20120283185
2012-11-08

FOOD COMPOSITION AND METHOD OF USING SAME

#4679
20120283181
2012-11-08

CRYSTAL FORMS OF SAXAGLIPTIN AND PROCESSES FOR PREPARING SAME

#4680
20120283177
2012-11-08

Schedules for administering combination therapies useful for treating persons afflicted with the human immunodeficiency virus (HIV)

#4681
20120283175
2012-11-08

ANTIBACTERIAL COMPOSITIONS

#4682
20120283169
2012-11-08

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#4683
20120283165
2012-11-08

NEUTRAL OR ALKALINE MEDIUM CHAIN PEROXYCARBOXYLIC ACID COMPOSITIONS AND METHODS EMPLOYING THEM

#4684
20120282645
2012-11-08

NANOPARTICLES

#4685
20120282360
2012-11-08

HERBAL PREPARATION TO RELIEVE INFLAMMATION AND SMOOTH MUSCLE CONTRACTION

#4686
20120282359
2012-11-08

Compositions, Kits, and Methods for the Treatment of Conditions Associated with Elevated Cholesterol Levels

#4687
20120282351
2012-11-08

System and Method for The Prevention of Bacterial and Fungal Infections Including Urinary Tract Infections (UTI) Using N-Halogenated Amino Acids

#4688
20120282348
2012-11-08

Antimicrobial silver hydrogel composition for the treatment of burns and wounds

#4689
20120282339
2012-11-08

Electrolyte purgative

#4690
20120282336
2012-11-08

Bilayer tablet formulations

#4691
20120282330
2012-11-08

Chinese herbal composition for the treatment of macular degeneration and the process for manufacturing the same

#4692
20120282324
2012-11-08

Methods for promoting the revascularization and reenervation of CNS lesions

#4693
20120282321
2012-11-08

Wound Dressings Containing Complexes of Transition Metals and Alginate for Elastase-Sequestering

#4694
20120282314
2012-11-08

DERMATOLOGICAL/COSMETIC SKIN DEPIGMENTING COMPOSITIONS

#4695
20120282301
2012-11-08

Porous calcium phosphate bone material

#4696
20120282280
2012-11-08

Bi-specific digoxigenin binding antibodies

#4697
20120282267
2012-11-08

Cathepsin inhibitors for the treatment of bone cancer and bone cancer pain

#4698
20120282255
2012-11-08

METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALCOHOLISM AND ALCOHOL DEPENDENCE

#4699
20120282252
2012-11-08

5Imidazoquinolines and Pyrimidine Derivatives as Potent Modulators of VEGF-Driven Angiogenic Processes

#4700
20120282251
2012-11-08

Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume

#4701
20120282244
2012-11-08

Use of at least one extract of flowers of alba plena for moisturizing the skin

#4702
20120282224
2012-11-08

MARKERS ASSOCIATED WITH RIBAVIRIN-INDUCED ANEMIA

#4703
20120282222
2012-11-08

Estrogen receptor ligand and/or interferon beta treatment for neurodegenerative diseases

#4704
20120282220
2012-11-08

Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

#4705
20120282219
2012-11-08

Peptidomimetic protease inhibitors

#4706
20120282204
2012-11-08

Protection against sunburn and skin problems with topical and orally-ingested dosages of zeaxanthin

#4707
20120282202
2012-11-08

AQUEOUS COMPOSITION FOR TOPICAL APPLICATION, METHOD OF PREPARATION, USES AND DEVICE

#4708
20120282195
2012-11-08

Topical skin care formulations comprising plant extracts

#4709
20120282194
2012-11-08

Topical skin care formulations comprising plant extracts

#4710
20120282189
2012-11-08

Improved Medicinal Aerosol Formulations

#4711
20120282185
2012-11-08

Particles for the treatment of cancer in combination with radiotherapy

#4712
20120282179
2012-11-08

Methods of Using C-Met Modulators

#4713
20120277693
2012-11-01

Method and apparatus for improving the appearance of nails affected by onychomycosis through the topical application of an aqueous solution containing boric acid and camphor or other terpenes

#4714
20120277690
2012-11-01

Degradable removable implant for the sustained release of an active compound

#4715
20120277660
2012-11-01

Composition and method for treatment of MRSA

#4716
20120277412
2012-11-01

Polynucleotide encoding anti-CD14 antibody fusion protein

#4717
20120277311
2012-11-01

LIPOXIN COMPOUNDS AND THEIR USE IN TREATING CELL PROLIFERATIVE DISORDERS

#4718
20120277300
2012-11-01

Compositions and methods for inducing bone growth and inhibiting bone loss

#4719
20120277295
2012-11-01

KIT FOR CANCER TREATMENT AND PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT

#4720
20120277293
2012-11-01

Immunostimulatory method

#4721
20120277271
2012-11-01

METHODS AND COMPOSITIONS

#4722
20120277264
2012-11-01

ANTITHROMBOTIC AGENT

#4723
20120277254
2012-11-01

Inhibitors of bruton's tyrosine kinase

#4724
20120277245
2012-11-01

Method of increasing intratumoral pHe and reducing acid-mediated invasion

#4725
20120277241
2012-11-01

Compounds, formulations, and methods for treating or preventing inflammatory skin disorders

#4726
20120277221
2012-11-01

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

#4727
20120277200
2012-11-01

Use of testosterone and a 5-HT1A agonist in the treatment of sexual dysfunction

#4728
20120277195
2012-11-01

Permeation enhancers for topical formulations

#4729
20120277193
2012-11-01

Synergistic Combination Therapy

#4730
20120277181
2012-11-01

Lactulose for bowel evacuation

#4731
20120277180
2012-11-01

Cofactors and Methods for Use for Individuals

#4732
20120277176
2012-11-01

Protein Arginine Deiminase inhibitors as novel therapeutics for rheumatoid arthritis and cancer

#4733
20120277175
2012-11-01

PHARMACEUTICAL COMBINATIONS, PHARMACEUTICAL COMPOSITIONS, MEDICAMENT AND METHOD FOR THE TREATMENT OF ANIMALS

#4734
20120277171
2012-11-01

Warmi®, natural alternative for the treatment of menopause

#4735
20120277170
2012-11-01

NUTRITIVE COMPOSITIONS AND METHODS OF USING SAME

#4736
20120277151
2012-11-01

GLP-1 PHARMACEUTICAL COMPOSITIONS

#4737
20120277149
2012-11-01

PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF METABOLIC DISORDERS

#4738
20120277147
2012-11-01

PREVENTION OF HYPOGLYCAEMIA IN DIABETES MELLITUS TYPE 2 PATIENTS

#4739
20120276591
2012-11-01

Polynucleotides encoding antibodies against sclerostin and uses therefor

#4740
20120276229
2012-11-01

PRIMARY BILE ACID AND SECONDARY BILE ACID GENERATION REGULATOR

#4741
20120276226
2012-11-01

Compositions comprising extracts of southernwood and an amine compound

#4742
20120276220
2012-11-01

Method of Treating Hepatitis

#4743
20120276212
2012-11-01

COMPOSITION COMPRISING PLANT AND/OR FISH OILS AND NON-OXIDIZABLE FATTY ACID ENTITIES

#4744
20120276202
2012-11-01

Collagen matrix for tissue engineering

#4745
20120276201
2012-11-01

Compositions and method for treatment and prophylaxis of inflammatory bowel disease

#4746
20120276198
2012-11-01

Pharmaceutical composition for treating parkinson's disease and preparation method thereof

#4747
20120276194
2012-11-01

Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof

#4748
20120276188
2012-11-01

Biomaterials made from human hair

#4749
20120276173
2012-11-01

Glycosaminoglycan compositions in combination with stem cells

#4750
20120276171
2012-11-01

Micelle encapsulation of therapeutic agents

#4751
20120276165
2012-11-01

MICRO-COLLOIDAL SILICIC ACID/BORIC ACID COMPOSITION AND A METHOD OF PREPARING A BIOENHANCING SOLUTION AND POWDER

#4752
20120276160
2012-11-01

TOLEROGENIC SYNTHETIC NANOCARRIERS FOR REGULATING INNATE IMMUNE RESPONSES

#4753
20120276159
2012-11-01

Tolerogenic synthetic nanocarriers

#4754
20120276158
2012-11-01

Tolerogenic synthetic nanocarriers to reduce cytotoxic T lymphocyte responses

#4755
20120276157
2012-11-01

TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES

#4756
20120276156
2012-11-01

TOLEROGENIC SYNTHETIC NANOCARRIER COMPOSITIONS WITH TRANSPLANTABLE GRAFT ANTIGENS AND METHODS OF USE

#4757
20120276155
2012-11-01

Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells

#4758
20120276153
2012-11-01

Use of aerosolized levofloxacin for treating cystic fibrosis

#4759
20120276152
2012-11-01

SYSTEMS AND METHODS OF USING ZINC-CHELATOR TO TREAT MYOCARDIAL INFARCTION

#4760
20120276139
2012-11-01

USE OF NEWCASTLE DISEASE VIRUS-BASED VECTOR FOR INDUCING AN IMMUNE RESPONSE IN MAMMALS

#4761
20120276134
2012-11-01

Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells

#4762
20120276133
2012-11-01

Tolerogenic synthetic nanocarriers for inducing regulatory B cells

#4763
20120276123
2012-11-01

Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compounds and methods of use thereof

#4764
20120276121
2012-11-01

Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases

#4765
20120276116
2012-11-01

Prevention and Treatment of Amyloidogenic Disease

#4766
20120276109
2012-11-01

Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins

#4767
20120276108
2012-11-01

MONOSACCHARIDE-BASED COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE AND INFLAMMATORY DERMATOLOGICAL DISEASES

#4768
20120276093
2012-11-01

Therapeutic combination comprising a Cdc7 inhibitor and an anti-neoplastic agent

#4769
20120276088
2012-11-01

Small molecule trail gene induction by normal and tumor cells as an anticancer therapy

#4770
20120276087
2012-11-01

Methods and compositions using PDE4 inhibitors for the treatment and management of autoimmune and inflammatory diseases

#4771
20120276085
2012-11-01

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH AN ANTI-BCL-2 ACTIVE AGENT

#4772
20120276081
2012-11-01

BODY WEIGHT GAIN SUPPRESSING COMPOSITION AND FOOD PRODUCT COMPRISING THE SAME

#4773
20120276075
2012-11-01

SYNERGIC ACTION OF A PROLYL PROTEASE AND TRIPEPTIDYL PROTEASES

#4774
20120276074
2012-11-01

Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption

#4775
20120276061
2012-11-01

CD117+ cells and uses thereof

#4776
20120276053
2012-11-01

Oncolytic vaccinia virus cancer therapy

#4777
20120276051
2012-11-01

Inhibitors of hepatitis C virus

#4778
20120276050
2012-11-01

Methods and compositions of treating a flaviviridae family viral infection

#4779
20120276048
2012-11-01

EXTENDED TREATMENT OF MULTIPLE SCLEROSIS

#4780
20120276045
2012-11-01

TREATMENT OF SOLID CANCERS

#4781
20120276022
2012-11-01

Disinfecting agent comprising eugenol, terpineol and thymol

#4782
20120276019
2012-11-01

TISSUE KALLIKREIN FOR THE TREATMENT OF PARKINSON'S DISEASE

#4783
20120275999
2012-11-01

Oncolytic rhabdovirus

#4784
20120273982
2012-11-01

Preparation of an enteric release system

#4785
20120271251
2012-10-25

Skin care compositions and uses thereof

#4786
20120271032
2012-10-25

Preparation of a Therapeutic Composition

#4787
20120270924
2012-10-25

Oligomeric compounds for the modulation of HIF-1A expression

#4788
20120270916
2012-10-25

TOPICAL FORMULATIONS FOR TREATING NEUROPATHY

#4789
20120270900
2012-10-25

NOVEL METHOD OF TREATMENT

#4790
20120270896
2012-10-25

Antineoplastic Combinations Containing HKI-272 and Vinorelbine

#4791
20120270884
2012-10-25

Methods of Treating Aneurysmal Dilatation, Blood Vessel Wall Weakness and Specifically Abdominal Aortic and Thoracic Aneurysm Using Matrix Metalloprotease-2 Inhibitors

#4792
20120270880
2012-10-25

Pyrrolo [2,3—D] pyrazin—7—ylpyrimidine compounds

#4793
20120270860
2012-10-25

METHODS FOR TREATING OR PREVENTING ALCOHOL-RELATED DISORDERS OR CRAVING-RELATED DISORDERS

#4794
20120270856
2012-10-25

HETEROARYLOXY QUINAZOLINE DERIVATIVES

#4795
20120270849
2012-10-25

COMBINATIONS OF NIACIN, OMEGA-3 AND PLANT STEROLS/STANOLS FOR PREVENTION CHOLESTEROL TREATMENT

#4796
20120270842
2012-10-25

Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof

#4797
20120270837
2012-10-25

Compositions that treat or inhibit pathological conditions associated with inflammatory response

#4798
20120270836
2012-10-25

Therapeutic approaches for treating alzheimer'S disease

#4799
20120270835
2012-10-25

Medicinal Cream Made Using Hydrocortisone Acetate and A Process To Make The Same

#4800
20120270831
2012-10-25

Method for treating hematopoietic neoplasms